Sertraline 50 MG Oral Tablet — RxCUI 312941
RxNorm drug concept · Semantic clinical drug
RxCUI 312941
Semantic clinical drug · SCD
● Current RxNorm concept 121 FDA products
376 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI312941
Official nameSertraline 50 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assertraline (as sertraline HCl) 50 MG Oral Tablet; sertraline HCl 50 MG Oral Tablet
FDA products mapped121
Package NDCs mapped376
Reported Medicaid activity (SDUD)8,741,000 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Sertraline: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Most people don't feel the full benefit right away — sertraline typically takes several weeks to build up to steady levels in your body. Some people notice small improvements in sl...
- How long does it take for sertraline to start working?
- You should be cautious. Sertraline affects the blood's ability to clot, and combining it with aspirin, ibuprofen, naproxen, or other anti-inflammatory pain relievers raises your ri...
- Is it okay to take sertraline with ibuprofen or aspirin?
🕸️ Concept Web — How Sertraline 50 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Sertraline 50 MG Oral Tablet
RxCUI 312941 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Sertraline
36437IN
-
Sertraline
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Zoloft
82728BN
-
Zoloft
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Sertraline Oral Tablet
373868SCDF -
Sertraline Oral Product
1158194SCDG -
Sertraline Pill
1158195SCDG -
Sertraline Oral Tablet [Zoloft]
368413SBDF -
Zoloft Oral Product
1188168SBDG -
Zoloft Pill
1188169SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Sertraline Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Sertraline 50 MG
328671SCDC -
Sertraline 50 MG Oral Tablet [Zoloft]
208161SBD -
Sertraline 50 MG [Zoloft]
568885SBDC
-
Sertraline 50 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Sertraline 50 MG
SCDC · 328671 -
Sertraline Oral Tablet
SCDF · 373868 -
Sertraline Oral Product
SCDG · 1158194 -
Sertraline Pill
SCDG · 1158195
Brand-Name Concepts
-
Sertraline 50 MG Oral Tablet [Zoloft]
SBD · 208161 -
Sertraline 50 MG [Zoloft]
SBDC · 568885 -
Sertraline Oral Tablet [Zoloft]
SBDF · 368413 -
Zoloft Oral Product
SBDG · 1188168 -
Zoloft Pill
SBDG · 1188169 -
Zoloft
BN · 82728
📦 FDA Products & Package NDCs
121 products · 376 package NDCs
376 package NDCs map to RxCUI 312941 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 82009-0050-05 | 500 TABLET, FILM COATED in 1 BOTTLE (82009-050-05) | Sertraline Hydrochloride | Quallent Pharmaceuticals Health LLC | 2023-09-28 |
| 82868-0100-90 | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (82868-100-90) | Sertraline hydrochloride | Northwind Health Company, LLC | 2026-02-11 |
| 84386-0097-01 | 100 TABLET, FILM COATED in 1 BOTTLE (84386-097-01) | Sertraline Hydrochloride | Aurobindo Pharma Limited | 2025-11-20 |
| 84386-0097-05 | 500 TABLET, FILM COATED in 1 BOTTLE (84386-097-05) | Sertraline Hydrochloride | Aurobindo Pharma Limited | 2025-11-20 |
| 84386-0097-30 | 30 TABLET, FILM COATED in 1 BOTTLE (84386-097-30) | Sertraline Hydrochloride | Aurobindo Pharma Limited | 2025-11-20 |
| 84386-0097-50 | 50 TABLET, FILM COATED in 1 BOTTLE (84386-097-50) | Sertraline Hydrochloride | Aurobindo Pharma Limited | 2025-11-20 |
| 84386-0097-51 | 5000 TABLET, FILM COATED in 1 BOTTLE (84386-097-51) | Sertraline Hydrochloride | Aurobindo Pharma Limited | 2025-11-20 |
| 84386-0097-60 | 60 TABLET, FILM COATED in 1 BOTTLE (84386-097-60) | Sertraline Hydrochloride | Aurobindo Pharma Limited | 2025-11-20 |
| 84386-0097-90 | 90 TABLET, FILM COATED in 1 BOTTLE (84386-097-90) | Sertraline Hydrochloride | Aurobindo Pharma Limited | 2025-11-20 |
| 84386-0097-99 | 1000 TABLET, FILM COATED in 1 BOTTLE (84386-097-99) | Sertraline Hydrochloride | Aurobindo Pharma Limited | 2025-11-20 |
| 84386-0098-01 | 100 TABLET, FILM COATED in 1 BOTTLE (84386-098-01) | Sertraline Hydrochloride | Aurobindo Pharma Limited | 2025-11-20 |
| 84386-0098-05 | 500 TABLET, FILM COATED in 1 BOTTLE (84386-098-05) | Sertraline Hydrochloride | Aurobindo Pharma Limited | 2025-11-20 |
| 84386-0098-30 | 30 TABLET, FILM COATED in 1 BOTTLE (84386-098-30) | Sertraline Hydrochloride | Aurobindo Pharma Limited | 2025-11-20 |
| 84386-0098-50 | 50 TABLET, FILM COATED in 1 BOTTLE (84386-098-50) | Sertraline Hydrochloride | Aurobindo Pharma Limited | 2025-11-20 |
| 84386-0098-51 | 5000 TABLET, FILM COATED in 1 BOTTLE (84386-098-51) | Sertraline Hydrochloride | Aurobindo Pharma Limited | 2025-11-20 |
| 84386-0098-60 | 60 TABLET, FILM COATED in 1 BOTTLE (84386-098-60) | Sertraline Hydrochloride | Aurobindo Pharma Limited | 2025-11-20 |
| 84386-0098-90 | 90 TABLET, FILM COATED in 1 BOTTLE (84386-098-90) | Sertraline Hydrochloride | Aurobindo Pharma Limited | 2025-11-20 |
| 84386-0098-99 | 1000 TABLET, FILM COATED in 1 BOTTLE (84386-098-99) | Sertraline Hydrochloride | Aurobindo Pharma Limited | 2025-11-20 |
| 84386-0099-01 | 100 TABLET, FILM COATED in 1 BOTTLE (84386-099-01) | Sertraline Hydrochloride | Aurobindo Pharma Limited | 2025-11-20 |
| 84386-0099-05 | 500 TABLET, FILM COATED in 1 BOTTLE (84386-099-05) | Sertraline Hydrochloride | Aurobindo Pharma Limited | 2025-11-20 |
| 84386-0099-25 | 2500 TABLET, FILM COATED in 1 BOTTLE (84386-099-25) | Sertraline Hydrochloride | Aurobindo Pharma Limited | 2025-11-20 |
| 84386-0099-30 | 30 TABLET, FILM COATED in 1 BOTTLE (84386-099-30) | Sertraline Hydrochloride | Aurobindo Pharma Limited | 2025-11-20 |
| 84386-0099-50 | 50 TABLET, FILM COATED in 1 BOTTLE (84386-099-50) | Sertraline Hydrochloride | Aurobindo Pharma Limited | 2025-11-20 |
| 84386-0099-60 | 60 TABLET, FILM COATED in 1 BOTTLE (84386-099-60) | Sertraline Hydrochloride | Aurobindo Pharma Limited | 2025-11-20 |
| 84386-0099-90 | 90 TABLET, FILM COATED in 1 BOTTLE (84386-099-90) | Sertraline Hydrochloride | Aurobindo Pharma Limited | 2025-11-20 |
| 84386-0099-99 | 1000 TABLET, FILM COATED in 1 BOTTLE (84386-099-99) | Sertraline Hydrochloride | Aurobindo Pharma Limited | 2025-11-20 |
Observed labelers:
Aurobindo Pharma Limited (48) ·
Bryant Ranch Prepack (39) ·
A-S Medication Solutions (22) ·
Lupin Pharmaceuticals, Inc. (22) ·
Granules Pharmaceuticals Inc. (21) ·
Proficient Rx LP (21)
· +31 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.